Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

Modified-Release Drug Delivery Systems: Classification

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Drug Delivery Systems: Different Types

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intranasal mucoadhesive chitosan microspheres of ranolazine: Formulation, design, and pharmacokinetic evaluation.

Journal of pharmaceutical sciences·2026

Same author

Intranasal nanoemulsion-based <i>in-situ</i> gel containing dexlansoprazole: formulation development, <i>in-vitro</i> and <i>ex-vivo</i> evaluation.

Drug development and industrial pharmacy·2026

Same author

Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy.

Advances in immunology·2025

Same author

A Novel Neuroimaging Phenotype in the X-Linked Intellectual Disability with a Missense Mutation of CNKSR2 Gene.

Neurology India·2023

Same author

Neurofibromatosis Type-1 with Angiomatosis-like Neuroimaging Pattern in a Child.

Neurology India·2023

Same author

Targeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gynecological and other cancers.

Journal of controlled release : official journal of the Controlled Release Society·2016

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

Dendritic systems in drug delivery applications.

Narendra K Jain¹, Abhay Asthana

¹Dr Hari Singh Gour University, Pharmaceutics Research Laboratory, Department of Pharmaceutical Sciences, Sagar 4700 03, India. jnarendr@yahoo.co.in

Expert Opinion on Drug Delivery

|September 21, 2007

Summary

Dendrimers are versatile nanocarriers for drug delivery, offering tailored solutions for encapsulating or attaching therapeutic agents. Their unique structure presents challenges but holds significant promise for future nanomedicine applications.

More Related Videos

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices

Published on: January 30, 2026

Related Experiment Videos

Last Updated: Jul 11, 2026

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices

Published on: January 30, 2026

Area of Science:

Biomedicine
Nanotechnology
Drug Delivery Systems

Background:

Particulate carrier systems with controlled characteristics are crucial in biomedicine.
Dendrimers are emerging nanocarriers with unique properties for drug delivery.
Dendrimers can be engineered to encapsulate or chemically attach biologically active agents.

Purpose of the Study:

To explore the potential of dendrimers as novel drug delivery scaffolds.
To highlight the engineering capabilities of dendrimers for specific therapeutic needs.
To discuss the challenges and future roles of dendrimers in drug delivery.

Main Methods:

Review of dendrimer properties and applications in drug delivery.
Analysis of dendrimer architecture for drug encapsulation and attachment.
Discussion of in vivo metabolic fate considerations for modified dendrimers.

Main Results:

Dendrimers offer a unique platform for developing novel drug delivery scaffolds.
Their numerous surface functional groups allow precise tailoring for drug loading.
Modified dendrimer architecture presents challenges, particularly regarding in vivo behavior.

Conclusions:

Dendrimers show significant potential as advanced nanoconstructs for drug delivery.
Their adaptability makes them suitable for various drug categories.
Further research into their in vivo fate is essential for clinical translation.